Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 02, 2026 03:30 ET | Source: FundaMental Pharma GmbH

FundaMental Pharma appoints depression drug developer Dr. Hans Eriksson as Chief Medical Officer to advance its lead treatment-resistant depression candidate

FundaMental Pharma appoints depression drug developer Dr. Hans Eriksson as CMO to advance FMP374 toward the clinic in treatment-resistant depression.
November 19, 2013 08:02 ET | Source: Hiscox Insurance

Hiscox hires marketing veteran Russell Findlay as Head of US Marketing

NEW YORK, Nov. 19, 2013 (GLOBE NEWSWIRE) -- Hiscox, the international specialist insurer, today announced that Russell Findlay has been appointed as Head of Marketing for Hiscox USA based out of the...